Madrigal Pharmaceuticals (MDGL)
(Delayed Data from NSDQ)
$287.24 USD
+8.11 (2.91%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $287.65 +0.41 (0.14%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Earnings News For MDGL
-
Madrigal: Q1 Earnings Snapshot
-
Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
-
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results
-
Madrigal: Q4 Earnings Snapshot
-
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Third Quarter 2023 Financial Results
-
Madrigal: Q3 Earnings Snapshot
-
Madrigal: Q2 Earnings Snapshot
-
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Second Quarter 2023 Financial Results
-
Madrigal: Q1 Earnings Snapshot
-
Madrigal Pharmaceuticals Provides Corporate Updates and Reports First Quarter 2023 Financial Results
-
Madrigal: Q4 Earnings Snapshot
-
Madrigal Pharmaceuticals Provides Corporate Updates and Reports 2022 Fourth Quarter and Full Year Financial Results
-
Madrigal: Q3 Earnings Snapshot
-
Madrigal Pharmaceuticals Provides an Overview of Upcoming Resmetirom Data Presentations and Reports 2022 Third Quarter Financial Results
-
Madrigal: Q2 Earnings Snapshot
-
Madrigal Pharmaceuticals Provides Clinical and Business Updates and Reports 2022 Second Quarter Financial Results
-
Madrigal (MDGL) Posts Narrower than Expected Loss in Q2
-
Madrigal (MDGL) Q1 Earnings: Disappointment in the Cards?
-
Madrigal (MDGL) Q4 Earnings: What's in Store for the Stock?
-
What's in Store for Madrigal (MDGL) This Earnings Season?